Cerebral microhemorrhage and brain beta-amyloid in aging and Alzheimer disease
PA Yates, R Sirisriro, VL Villemagne, S Farquharson, CL Masters, CC Rowe
Neurology | LIPPINCOTT WILLIAMS & WILKINS | Published : 2011
Dr. Yates has received a research scholarship from the Commonwealth Government Dementia Collaborative Research Centres (Early Diagnosis and Prevention). Dr. Sirisriro reports no disclosures. Dr. Villemagne serves as on a scientific advisory board and as a consultant for Bayer Schering Pharma; serves as Associate Editor for the Journal of Alzheimer's Disease; and has received research support from the Commonwealth Scientific and Industrial Research Organisation (CSIRO). S. Farquharson and Prof. Masters report no disclosures. Prof. Rowe serves on scientific advisory boards for Bayer Schering Pharma, Elan Corporation, AstraZeneca, and GE Healthcare; has received speaker honoraria from Bayer Schering Pharma; has received research support from Bayer Schering Pharma, Avid Radiopharmaceuticals, Inc., Alzheimer's Association, and the Alzheimer's Drug Discovery Foundation; and his department has received funding from CSIRO, as a sponsor of AIBL, for PiB, and MRI scans.Supported by CSIRO and National Health and Medical Research Council Dementia Collaborative Research Centres Early Diagnosis and Prevention Program.